Week In Review: Haohai Biological Schedules $305 Million Hong Kong IPO
April 25, 2015 at 17:36 PM EDT
Shanghai Haohai Biological Technology, a company that makes medical products from absorbable biomedical materials, announced plans to raise as much as $305 million in an IPO on the Hong Kong Stock Exchange.
